site stats

Irinotecan dysarthria

WebJun 28, 2024 · Irinotecan-induced dysarthria has been reported in the literature, but the underlying mechanism of this neurotoxicity remains unclear. Here, we present a 35-year-old female with metastatic colon ... WebSep 19, 2001 · Irinotecan (CPT-11) is a semisynthetic analogue of camptothecin with antitumor activity in solid neoplasias. Camptothecin inhibits topoisomerase I and impedes the uncoiling of the DNA double helix, thus delaying its replication and cell division. Currently, CPT-11 combined with 5-fluorouracil (5-FU) is used as a first-line treatment of advanced ...

Full article: Irinotecan-induced central nervous system toxicity ...

WebJul 26, 2024 · The patient was able to tolerate this reaction and received 20 cycles of irinotecan-based chemotherapy despite experiencing the muscle twitching with every cycle at the same onset, duration, and severity. It is possible that competitive metabolism by concomitant medications metabolized by CYP3A4 or UGT1A1 was responsible for this … WebMay 1, 2024 · Early diarrhea (occurring during or shortly after infusion of Irinotecan hydrochloride injection) is usually transient and infrequently severe. It may be accompanied by cholinergic symptoms of rhinitis, increased salivation, miosis, lacrimation, diaphoresis, flushing, and intestinal hyperperistalsis that can cause abdominal cramping. sylvester townsend https://segnicreativi.com

Irinotecan-Associated Dysarthria in Patients with …

WebBACKGROUND: Irinotecan, a topoisomerase I inhibitor, is a cytotoxic chemotherapeutic agent used to treat multiple malignancies, including those of colorectal, pancreatic, cervical, esophageal, gastric, and lung origin.Dysarthria, a state of difficult or unclear articulation of speech, has been reported as a rare side effect of irinotecan through multiple case … WebCase Series of Irinotecan-Induced-Dysarthria: A Review of Literature and Proposition of a Pre-Medication Regimen. Mathews J Gastroenterol Hepatol 4(1): 13. 2 regimen. Through a retrospective and ... WebJun 28, 2024 · Dysarthria, a state of difficult or unclear articulation of speech, has been reported as a rare side effect of irinotecan through multiple case reports and case series, … sylvester thomas obituary

Dysarthrie lors de l’administration d’irinotécan Request PDF

Category:Irinotecan-induced dysarthria: A case report and review of the ...

Tags:Irinotecan dysarthria

Irinotecan dysarthria

National Center for Biotechnology Information

WebJul 1, 2013 · Summary A 49-year-old man with meta-static colon cancer undergoing treatment with i.v. irinotecan (180 mg/m 2 to be infused over 120 minutes) as part of a … WebJul 1, 2008 · Europe PMC is an archive of life sciences journal literature.

Irinotecan dysarthria

Did you know?

WebJan 18, 2012 · Irinotecan is a prodrug that requires in vivo activation by carboxylesterases to yield its active and potent metabolite, SN-38, which works in a cell cycle phase-specific (S phase) mechanism to... WebSep 2, 2024 · Hence irinotecan may cause overstimulation of hypoglossal nerve leading to dysarthria. Oxaliplatin is known to potentiate the cholinergic effects of irinotecan by …

WebJun 28, 2024 · Dysarthria, a state of difficult or unclear articulation of speech, has been reported as a rare side effect of irinotecan through multiple case reports and case series, …

WebJan 19, 2013 · Irinotecan. A 34-year-old man with metastatic sarcoma and a 63-year-old woman with disseminated adenocarcinoma developed CNS toxicity with dysarthria during treatment with irinotecan. The woman also experienced an acute cholinergic syndrome. The man, who had experienced partial remission of his sarcoma following antineoplastic … WebThe topoisomerase I inhibitor irinotecan is a widely used cytotoxic drug [1]. The most frequent side effects of irinotecan include acute cholinergic syn-drome (ACS), delayed-onset diarrhoea, and bone-marrow suppression [1]. Much more unusual is the occurrence of irinotecan-induced central nervous system (CNS) toxicity with dysarthria as the pre-

WebJan 18, 2012 · Irinotecan is a prodrug that requires in vivo activation by carboxylesterases to yield its active and potent metabolite, SN-38, which works in a cell cycle phase-specific (S …

WebJun 28, 2024 · Dysarthria, a state of difficult or unclear articulation of speech, has been reported as a rare side effect of irinotecan through multiple case reports and case series, but with limited published data aimed at understanding the underlying mechanism and effective management strategies. sylvester the talking cat dieWebAbstract. Irinotecan (Camptosar ©, CPT-11), a topoisomerase I inhibitor, is a commonly used cytotoxic chemotherapeutic in the treatment of multiple malignancies, particularly … tft hechicerosWebJul 8, 2009 · The most frequent side effects of irinotecan include acute cholinergic syndrome (ACS), delayed-onset diarrhoea, and bone-marrow suppression [1]. Much more unusual is the occurrence of irinotecan-induced central nervous system (CNS) toxicity with dysarthria as the predominant symptom. sylvester the talking kitty cat